PROTAGENIC THERAPEUTICS, INC.NEW (PTIX) financial statements (2021 and earlier)

Company profile

Business Address 149 FIFTH AVENUE
NEW YORK, NY 10010
State of Incorp. DE
Fiscal Year End December 31
SIC 7389 - Business Services, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6717993621,6853,10062
Cash and cash equivalents6717993624003,10062
Short-term investments   1,286  
Prepaid expense2084383956070
Other undisclosed current assets  250   
Total current assets:8798426961,7803,161132
Noncurrent Assets
Property, plant and equipment 01111
Total noncurrent assets: 01111
TOTAL ASSETS:8798426971,7813,162133
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:572865232136168168
Accrued liabilities142163101115 
Interest and dividends payable     21
Other undisclosed accounts payable and accrued liabilities430702222125153147
Derivative instruments and hedges, liabilities84332676426517 
Other undisclosed current liabilities     21
Total current liabilities:6551,197908562685189
Noncurrent Liabilities
Long-term debt and lease obligation1,081175   515
Long-term debt, excluding current maturities1,081175   515
Other undisclosed noncurrent liabilities292105    
Total noncurrent liabilities:1,374279   515
Total liabilities:2,0291,477908562685704
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,150)(634)(211)1,2192,477(497)
Preferred stock     5
Common stock11111 
Additional paid in capital16,72014,68713,35812,22811,2401,053
Accumulated other comprehensive loss(172)(172)(171)(168)(182) 
Accumulated deficit(17,699)(15,150)(13,399)(10,842)(8,582)(1,555)
Other undisclosed stockholders' equity attributable to parent00000 
Stockholders' equity attributable to noncontrolling interest     (74)
Total stockholders' equity:(1,150)(634)(211)1,2192,477(571)
TOTAL LIABILITIES AND EQUITY:8798426971,7813,162133

Income statement (P&L) ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
Gross profit:  3141 
Operating expenses(2,552)(2,086)(2,314)(2,365)(2,234)(491)
Other undisclosed operating loss  (3)(14)(1) 
Operating loss:(2,552)(2,086)(2,314)(2,365)(2,234)(491)
Nonoperating income (expense)3335(243)106(42)(10)
Foreign currency transaction loss, before tax    (7) 
Other nonoperating income (expense)(246)(13)   8
Interest and debt expense (100)  (7)(18)
Other undisclosed income from continuing operations before equity method investments, income taxes 100  7 
Loss from continuing operations before equity method investments, income taxes:(2,549)(1,751)(2,558)(2,260)(2,276)(519)
Other undisclosed income from continuing operations before income taxes     18
Loss from continuing operations before income taxes:(2,549)(1,751)(2,558)(2,260)(2,276)(501)
Income tax benefit     171
Loss before gain (loss) on sale of properties:(2,549)(1,751)(2,558)(2,260)(2,276)(330)
Other undisclosed net loss     (171)
Net loss:(2,549)(1,751)(2,558)(2,260)(2,276)(501)
Net income attributable to noncontrolling interest     25
Net loss available to common stockholders, diluted:(2,549)(1,751)(2,558)(2,260)(2,276)(476)

Comprehensive Income ($ in thousands)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
6/30/2015
Net loss:(2,549)(1,751)(2,558)(2,260)(2,276)(501)
Other comprehensive income (loss) 5(6)   
Comprehensive loss:(2,549)(1,746)(2,564)(2,260)(2,276)(501)
Comprehensive income, net of tax, attributable to noncontrolling interest     25
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(11)414(33) 
Comprehensive loss, net of tax, attributable to parent:(2,548)(1,758)(2,560)(2,246)(2,309)(476)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: